Piramed's Acquisition

Piramed was acquired by Roche Holding on April 15, 2008.

Piramed is a biotech company whose mission is to discover and develop new medicines primarily for the treatment of cancer and immune inflammatory disorders such as arthritis and asthma. Piramed specia…

Articles about Piramed's Acquisition: